A wide range of people can benefit from high dose vitamin C IVs, as the treatment helps to boost immunity, combat toxins and cellular damage, and improve collagen production throughout the body
Retatrutide (LY3437943), a novel triple agonist targeting glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1 and glucagon receptors, has shown promise in early trials for managing these conditions
The right choice depends on medical history, goals, tolerability, and what is happening with the underlying metabolic picture
In research trials (5) all type 2 diabetic medication was stopped on the day that patient started the 800 kcal programme, however ultimately this decision is up to your GP or diabetes care team and you should not make any medication adjustments without speaking to them
Liquid format for convenience